- Home
- ABSI vs ZTR Comparison
ABSI vs ZTR Comparison
Compare ABSI & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- ZTR
- Stock Information
- Founded
- ABSI 2011
- ZTR 1988
- Country
- ABSI United States
- ZTR Australia
- Employees
- ABSI N/A
- ZTR N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- ZTR Investment Managers
- Sector
- ABSI Health Care
- ZTR Finance
- Exchange
- ABSI Nasdaq
- ZTR Nasdaq
- Market Cap
- ABSI 338.0M
- ZTR 349.4M
- IPO Year
- ABSI 2021
- ZTR N/A
- Fundamental
- Price
- ABSI $2.39
- ZTR $6.37
- Analyst Decision
- ABSI Strong Buy
- ZTR
- Analyst Count
- ABSI 5
- ZTR 0
- Target Price
- ABSI $7.98
- ZTR N/A
- AVG Volume (30 Days)
- ABSI 4.4M
- ZTR 219.4K
- Earning Date
- ABSI 08-12-2025
- ZTR 01-01-0001
- Dividend Yield
- ABSI N/A
- ZTR 12.09%
- EPS Growth
- ABSI N/A
- ZTR N/A
- EPS
- ABSI N/A
- ZTR N/A
- Revenue
- ABSI $4,138,000.00
- ZTR N/A
- Revenue This Year
- ABSI $44.71
- ZTR N/A
- Revenue Next Year
- ABSI $374.26
- ZTR N/A
- P/E Ratio
- ABSI N/A
- ZTR N/A
- Revenue Growth
- ABSI 27.32
- ZTR N/A
- 52 Week Low
- ABSI $2.01
- ZTR $4.50
- 52 Week High
- ABSI $6.33
- ZTR $6.60
- Technical
- Relative Strength Index (RSI)
- ABSI 33.33
- ZTR 64.07
- Support Level
- ABSI $2.50
- ZTR $6.27
- Resistance Level
- ABSI $2.73
- ZTR $6.35
- Average True Range (ATR)
- ABSI 0.18
- ZTR 0.04
- MACD
- ABSI -0.04
- ZTR 0.01
- Stochastic Oscillator
- ABSI 1.94
- ZTR 85.06
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.